Innoterra Ltd, the Indian arm of Swiss agritech firm Innoterra AG, is preparing for an Initial Public Offering (IPO). The company plans to ...

UTI Mutual Fund has significantly boosted its stake in MCX, acquiring nearly 15 lakh shares for a substantial Rs 425 crore via an open mark...

Promoters and large shareholders are cashing in on a stock market rebound, offloading shares worth over ₹24,000 crore in May and June. This...

Fuel stations can now freely sell petrol and diesel to all customers. The government has removed restrictions on bulk buyers purchasing fue...

India has removed restrictions on commercial buyers purchasing petrol and diesel from retail outlets, effective July 1. These emergency mea...

Celebrity fitness coach Siddhartha Singh debunks the myth that certain foods hinder weight loss, asserting that overeating, not the food it...

Before the U.S. and Israel launched the war on February 28, about a third of globally traded urea - the world's most widely used fertiliser...

Indian stock markets achieved their longest winning streak in seven months, with the Nifty 50 and BSE Sensex closing higher. Falling crude ...

Global investment firm Alpha Wave Global has divested its entire 1.93% stake in logistics giant Delhivery for Rs 665 crore. This significan...

Qualcomm is acquiring AI startup Modular for nearly $4 billion in an all-stock deal. This move aims to enhance Qualcomm's software capabili...

Mamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This stra...

Honasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's ...

Honasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...

Healthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...

Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...

Aurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...

India's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...